Mayersohn Joel David has filed 5 insider transactions across 1 company since December 2024.
Most recent transaction: a grant/award of 300000 shares of CITIUS ONCOLOGY, INC. ($CTOR) on September 19, 2025.
| Transaction Date | Company | Ticker | Insider Name | Title | Transaction Type | Security | Shares | Price | Shares Owned Following | Total Shares Outstanding | % of Owned | % of Outstanding |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sept. 19, 2025 | CITIUS ONCOLOGY, INC. | $CTOR | Mayersohn Joel David | Director | A | Common Stock | 300000 | $0.00 | 321,228.0000 | 71,552,402 | 1413.23% | 0.42% |
| Sept. 19, 2025 | CITIUS ONCOLOGY, INC. | $CTOR | Mayersohn Joel David | Director | A | Common Stock | 300000 | $0.00 | 321,228.0000 | 71,552,402 | 1413.23% | 0.42% |
| Sept. 19, 2025 | CITIUS ONCOLOGY, INC. | $CTOR | Mayersohn Joel David | Director | A | Common Stock | 300000 | $0.00 | 321,228.0000 | 71,552,402 | 1413.23% | 0.42% |
| July 28, 2025 | CITIUS ONCOLOGY, INC. | $CTOR | Mayersohn Joel David | Director | J | Common Stock | 21228 | $0.00 | 21,228.0000 | 71,552,402 | 9999.99% | 0.03% |
| Dec. 12, 2024 | CITIUS ONCOLOGY, INC. | $CTOR | Mayersohn Joel David | Director | A | Stock Option (Right to Buy) | 250000 | $0.00 | 250,000.0000 | 68,053,607 | 9999.99% | 0.37% |